相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Zr-89-labeled nivolumab for imaging of T-cell infiltration in a humanized murine model of lung cancer
Christopher G. England et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2018)
Cord blood NK cells engineered to express IL-15 and a CD19-targeted CAR show long-term persistence and potent antitumor activity
E. Liu et al.
LEUKEMIA (2018)
Humanized mice in studying efficacy and mechanisms of PD-1-targeted cancer immunotherapy
Minan Wang et al.
FASEB JOURNAL (2018)
HLA-DPB1 mismatch alleles represent powerful leukemia rejection antigens in CD4 T-cell immunotherapy after allogeneic stem-cell transplantation
W. Herr et al.
LEUKEMIA (2017)
IL-15 enhances the anti-tumor activity of trastuzumab against breast cancer cells but causes fatal side effects in humanized tumor mice (HTM)
Anja K. Wege et al.
ONCOTARGET (2017)
Genetically engineered mesenchymal stromal cells produce IL-3 and TPO to further improve human scaffold-based xenograft models
Marco Carretta et al.
EXPERIMENTAL HEMATOLOGY (2017)
mRNA-mediated glycoengineering ameliorates deficient homing of human stem cell-derived hematopoietic progenitors
Jungmin Lee et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Current status and perspectives of patient-derived xenograft models in cancer research
Yunxin Lai et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
Comparison of Human Hematopoietic Reconstitution in Different Strains of Immunodeficient Mice
Ashley I. Beyer et al.
STEM CELLS AND DEVELOPMENT (2017)
A Comprehensive Patient-Derived Xenograft Collection Representing the Heterogeneity of Melanoma
Clemens Krepler et al.
CELL REPORTS (2017)
In Vivo Efficacy of Umbilical Cord Blood Stem Cell-Derived NK Cells in the Treatment of Metastatic Colorectal Cancer
John P. Veluchamy et al.
FRONTIERS IN IMMUNOLOGY (2017)
Novel Strategy to Expand Super-Charged NK Cells with Significant Potential to Lyse and Differentiate Cancer Stem Cells: Differences in NK Expansion and Function between Healthy and Cancer Patients
Kawaljit Kaur et al.
FRONTIERS IN IMMUNOLOGY (2017)
Humanized Mice with Subcutaneous Human Solid Tumors for Immune Response Analysis of Vaccinia Virus-Mediated Oncolysis
Desislava Tsoneva et al.
MOLECULAR THERAPY-ONCOLYTICS (2017)
NOG-hIL-4-Tg, a new humanized mouse model for producing tumor antigen-specific IgG antibody by peptide vaccination
Yoshie Kametani et al.
PLOS ONE (2017)
Creation of an immunodeficient HLA-transgenic mouse (HUMAMICE) and functional validation of human immunity after transfer of HLA-matched human cells
Yang Zeng et al.
PLOS ONE (2017)
A novel humanized mouse model with significant improvement of class-switched, antigen-specific antibody production
Hua Yu et al.
BLOOD (2017)
Induction of WT1-specific human CD8+ T cells from human HSCs in HLA class I Tg NOD/SCID/IL2rgKO mice
Yuho Najima et al.
BLOOD (2016)
The combinational therapy of trastuzumab and cetuximab inhibits tumor growth in a patient-derived tumor xenograft model of gastric cancer
C. J. Wang et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2016)
XactMice: humanizing mouse bone marrow enables microenvironment reconstitution in a patient-derived xenograft model of head and neck cancer
J. J. Morton et al.
ONCOGENE (2016)
Establishing human leukemia xenograft mouse models by implanting human bone marrow-like scaffold-based niches
Antonella Antonelli et al.
BLOOD (2016)
The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice
Elizabeth C. Townsend et al.
CANCER CELL (2016)
A Novel Carcinoembryonic Antigen T-Cell Bispecific Antibody (CEA TCB) for the Treatment of Solid Tumors
Marina Bacac et al.
CLINICAL CANCER RESEARCH (2016)
IL15 Trispecific Killer Engagers (TriKE) Make Natural Killer Cells Specific to CD33+ Targets While Also Inducing Persistence, In Vivo Expansion, and Enhanced Function
Daniel A. Vallera et al.
CLINICAL CANCER RESEARCH (2016)
NSG™-Quad mice, a new humanized mouse model with improved human innate immune cell development
L. C. Yao et al.
EUROPEAN JOURNAL OF CANCER (2016)
Human CAR T cells with cell-intrinsic PD-1 checkpoint blockade resist tumor-mediated inhibition
Leonid Cherkassky et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Microenvironment-dependent growth of preneoplastic and malignant plasma cells in humanized mice
Rituparna Das et al.
NATURE MEDICINE (2016)
Human melanoma immunotherapy using tumor antigen-specific T cells generated in humanized mice
Zheng Hu et al.
ONCOTARGET (2016)
Cetuximab response in CRC patient-derived xenografts seems predicted by an expression based Ras pathway signature
Sheng Guo et al.
ONCOTARGET (2016)
PD-1/CTLA-4 Blockade Inhibits Epstein-Barr Virus-Induced Lymphoma Growth in a Cord Blood Humanized-Mouse Model
Shi-Dong Ma et al.
PLOS PATHOGENS (2016)
TGN1412 Induces Lymphopenia and Human Cytokine Release in a Humanized Mouse Model
Sabrina Weissmueller et al.
PLOS ONE (2016)
NSG Mice Provide a Better Spontaneous Model of Breast Cancer Metastasis than Athymic (Nude) Mice
Madhavi Puchalapalli et al.
PLOS ONE (2016)
Patient-derived tumor xenografts in humanized NSG-SGM3 mice: A new immuno-oncology platform
Li-Chin Yao et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Natural killer (NK) cells inhibit systemic metastasis of glioblastoma cells and have therapeutic effects against glioblastomas in the brain
Se Jeong Lee et al.
BMC CANCER (2015)
Small Molecule Inhibition of ERK Dimerization Prevents Tumorigenesis by RAS-ERK Pathway Oncogenes
Ana Herrero et al.
CANCER CELL (2015)
Paradox-Breaking RAF Inhibitors that Also Target SRC Are Effective in Drug-Resistant BRAF Mutant Melanoma
Maria Romina Girotti et al.
CANCER CELL (2015)
Nivolumab and Urelumab Enhance Antitumor Activity of Human T Lymphocytes Engrafted in Rag2-/-IL2Rγnull Immunodeficient Mice
Miguel F. Sanmamed et al.
CANCER RESEARCH (2015)
CD8-positive Lymphocytes in Graft-Versus-Host Disease of Humanized NOD
S. T. Laing et al.
JOURNAL OF COMPARATIVE PATHOLOGY (2015)
NK Cells Preferentially Target Tumor Cells with a Cancer Stem Cell Phenotype
Erik Ames et al.
JOURNAL OF IMMUNOLOGY (2015)
Human anti-CAIX antibodies mediate immune cell inhibition of renal cell carcinoma in vitro and in a humanized mouse model in vivo
De-Kuan Chang et al.
MOLECULAR CANCER (2015)
High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response
Hui Gao et al.
NATURE MEDICINE (2015)
Cancer-targeted IL-12 controls human rhabdomyosarcoma by senescence induction and myogenic differentiation
Karin Schilbach et al.
ONCOIMMUNOLOGY (2015)
Human tumor infiltrating lymphocytes cooperatively regulate prostate tumor growth in a humanized mouse model
Michael D. Roth et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2015)
Epigenetic and in vivo comparison of diverse MSC sources reveals an endochondral signature for human hematopoietic niche formation
Andreas Reinisch et al.
BLOOD (2015)
Dynamics of genomic clones in breast cancer patient xenografts at single-cell resolution
Peter Eirew et al.
NATURE (2015)
CAR-Engineered NK Cells Targeting Wild-Type EGFR and EGFRvIII Enhance Killing of Glioblastoma and Patient-Derived Glioblastoma Stem Cells
Jianfeng Han et al.
SCIENTIFIC REPORTS (2015)
Targeting CD20+ Aggressive B-cell Non-Hodgkin Lymphoma by Anti-CD20 CAR mRNA-Modified Expanded Natural Killer Cells In Vitro and in NSG Mice
Yaya Chu et al.
CANCER IMMUNOLOGY RESEARCH (2015)
Setting up a wide panel of patient-derived tumor xenografts of non-small cell lung cancer by improving the preanalytical steps
Marius Ilie et al.
CANCER MEDICINE (2015)
Examining the utility of patient-derived xenograft mouse models
Samuel Aparicio et al.
NATURE REVIEWS CANCER (2015)
Advances in patient-derived tumor xenografts: From target identification to predicting clinical response rates in oncology
Edward Rosfjord et al.
BIOCHEMICAL PHARMACOLOGY (2014)
Patient-Derived Xenografts for Individualized Care in Advanced Sarcoma
Justin Stebbing et al.
CANCER (2014)
Functional Heterogeneity of Genetically Defined Subclones in Acute Myeloid Leukemia
Jeffery M. Klco et al.
CANCER CELL (2014)
A Novel Chimeric Antigen Receptor Against Prostate Stem Cell Antigen Mediates Tumor Destruction in a Humanized Mouse Model of Pancreatic Cancer
Daniel Abate-Daga et al.
HUMAN GENE THERAPY (2014)
Regorafenib (BAY 73-4506): Antitumor and antimetastatic activities in preclinical models of colorectal cancer
Roberta Schmieder et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Dendritic Cell-Mediated Immune Humanization of Mice: Implications for Allogeneic and Xenogeneic Stem Cell Transplantation
Gustavo Salguero et al.
JOURNAL OF IMMUNOLOGY (2014)
Co-transplantation of human hematopoietic stem cells and human breast cancer cells in NSG mice A novel approach to generate tumor cell specific human antibodies
Anja K. Wege et al.
MABS (2014)
Development and function of human innate immune cells in a humanized mouse model
Anthony Rongvaux et al.
NATURE BIOTECHNOLOGY (2014)
Immune Humanization of Immunodeficient Mice Using Diagnostic Bone Marrow Aspirates from Carcinoma Patients
Melanie Werner-Klein et al.
PLOS ONE (2014)
Regional delivery of mesothelin-targeted CAR T cell therapy generates potent and long-lasting CD4-dependent tumor immunity
Prasad S. Adusumilli et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
CD44v6-targeted T cells mediate potent antitumor effects against acute myeloid leukemia and multiple myeloma
Monica Casucci et al.
BLOOD (2013)
Stromal disrupting effects of nab-paclitaxel in pancreatic cancer
R. Alvarez et al.
BRITISH JOURNAL OF CANCER (2013)
Targeting BCL-2 with the BH3 Mimetic ABT-199 in Estrogen Receptor-Positive Breast Cancer
Francois Vaillant et al.
CANCER CELL (2013)
A Renewable Tissue Resource of Phenotypically Stable, Biologically and Ethnically Diverse, Patient-Derived Human Breast Cancer Xenograft Models
Xiaomei Zhang et al.
CANCER RESEARCH (2013)
Development and Characterization of HPV-Positive and HPV-Negative Head and Neck Squamous Cell Carcinoma Tumorgrafts
Randall J. Kimple et al.
CLINICAL CANCER RESEARCH (2013)
Intraperitoneal delivery of human natural killer cells for treatment of ovarian cancer in a mouse xenograft model
Melissa A. Geller et al.
CYTOTHERAPY (2013)
A patient tumor transplant model of squamous cell cancer identifies PI3K inhibitors as candidate therapeutics in defined molecular bins
Stephen B. Keysar et al.
MOLECULAR ONCOLOGY (2013)
Combinatorial antigen recognition with balanced signaling promotes selective tumor eradication by engineered T cells
Christopher C. Kloss et al.
NATURE BIOTECHNOLOGY (2013)
Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay
Irene Baccelli et al.
NATURE BIOTECHNOLOGY (2013)
Natural Killer Cells Generated from Cord Blood Hematopoietic Progenitor Cells Efficiently Target Bone Marrow-Residing Human Leukemia Cells in NOD/SCID/IL2Rgnull Mice
Jeannette Cany et al.
PLOS ONE (2013)
Engineering of a functional bone organ through endochondral ossification
Celeste Scotti et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Genomic responses in mouse models poorly mimic human inflammatory diseases
Junhee Seok et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Variable Clonal Repopulation Dynamics Influence Chemotherapy Response in Colorectal Cancer
Antonija Kreso et al.
SCIENCE (2013)
A subset of gastric cancers with EGFR amplification and overexpression respond to cetuximab therapy
Lianhai Zhang et al.
SCIENTIFIC REPORTS (2013)
Preclinical Efficacy and Immunological Safety of FR104, an Antagonist Anti-CD28 Monovalent Fab' Antibody
N. Poirier et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2012)
Engraftment of human HSCs in nonirradiated newborn NOD-scid IL2rγnull mice is enhanced by transgenic expression of membrane-bound human SCF
Michael A. Brehm et al.
BLOOD (2012)
e-Blood Reconstructing the human hematopoietic niche in immunodeficient mice: opportunities for studying primary multiple myeloma
Richard W. J. Groen et al.
BLOOD (2012)
Blood vessel hyperpermeability and pathophysiology in human tumour xenograft models of breast cancer: a comparison of ectopic and orthotopic tumours
Karyn S. Ho et al.
BMC CANCER (2012)
Patient-derived luminal breast cancer xenografts retain hormone receptor heterogeneity and help define unique estrogen-dependent gene signatures
Peter Kabos et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Targeting of 4-1BB by monoclonal antibody PF-05082566 enhances T-cell function and promotes anti-tumor activity
Timothy S. Fisher et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
A Universal Strategy for Adoptive Immunotherapy of Cancer through Use of a Novel T-cell Antigen Receptor
Katarzyna Urbanska et al.
CANCER RESEARCH (2012)
T-cell receptor gene therapy targeting melanoma-associated antigen-A4 inhibits human tumor growth in non-obese diabetic/SCID/γcnull mice
Yoshitaka Shirakura et al.
CANCER SCIENCE (2012)
Characterization of a Large Panel of Patient-Derived Tumor Xenografts Representing the Clinical Heterogeneity of Human Colorectal Cancer
Sylvia Julien et al.
CLINICAL CANCER RESEARCH (2012)
Stem-like Tumor-Initiating Cells Isolated from IL13Rα2 Expressing Gliomas Are Targeted and Killed by IL13-Zetakine-Redirected T Cells
Christine E. Brown et al.
CLINICAL CANCER RESEARCH (2012)
Molecular profiling indicates orthotopic xenograft of glioma cell lines simulate a subclass of human glioblastoma
Uma T. Shankavaram et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2012)
IL-15 protects NKT cells from inhibition by tumor-associated macrophages and enhances antimetastatic activity
Daofeng Liu et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
GM-CSF and IL-4 Stimulate Antibody Responses in Humanized Mice by Promoting T, B, and Dendritic Cell Maturation
Qingfeng Chen et al.
JOURNAL OF IMMUNOLOGY (2012)
Residual dormant cancer stem-cell foci are responsible for tumor relapse after antiangiogenic metronomic therapy in hepatocellular carcinoma xenografts
Ines Martin-Padura et al.
LABORATORY INVESTIGATION (2012)
Editing T cell specificity towards leukemia by zinc finger nucleases and lentiviral gene transfer
Elena Provasi et al.
NATURE MEDICINE (2012)
Evolution of genetic and genomic features unique to the human lineage
Majesta O'Bleness et al.
NATURE REVIEWS GENETICS (2012)
Human Solid Tumor Xenografts in Immunodeficient Mice Are Vulnerable to Lymphomagenesis Associated with Epstein-Barr Virus
Kui Chen et al.
PLOS ONE (2012)
Sensitization of BCL-2-expressing breast tumors to chemotherapy by the BH3 mimetic ABT-737
Samantha R. Oakes et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Tumor initiating but differentiated luminal-like breast cancer cells are highly invasive in the absence of basal-like activity
Jiyoung Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors
Stephen B. Willingham et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Evolutionary Dynamics of Gene and Isoform Regulation in Mammalian Tissues
Jason Merkin et al.
SCIENCE (2012)
The Evolutionary Landscape of Alternative Splicing in Vertebrate Species
Nuno L. Barbosa-Morais et al.
SCIENCE (2012)
A Validated Tumorgraft Model Reveals Activity of Dovitinib Against Renal Cell Carcinoma
S. Sivanand et al.
Science Translational Medicine (2012)
Efficient differentiation and function of human macrophages in humanized CSF-1 mice
Chozhavendan Rathinam et al.
BLOOD (2011)
A novel adoptive transfer model of chronic lymphocytic leukemia suggests a key role for T lymphocytes in the disease
Davide Bagnara et al.
BLOOD (2011)
Development of human CD4+FoxP3+ regulatory T cells in human stem cell factor-, granulocyte-macrophage colony-stimulating factor-, and interleukin-3-expressing NOD-SCID IL2Rγnull humanized mice
Eva Billerbeck et al.
BLOOD (2011)
Therapeutic Antibody Targeting of CD47 Eliminates Human Acute Lymphoblastic Leukemia
Mark P. Chao et al.
CANCER RESEARCH (2011)
Human peripheral blood CD4 T cell-engrafted non-obese diabetic-scid IL2rγnull H2-Ab1tm1Gru Tg (human leucocyte antigen D-related 4) mice: a mouse model of human allogeneic graft-versus-host disease
L. Covassin et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2011)
Tumor Growth Inhibition by Olaparib in BRCA2 Germline-Mutated Patient-Derived Ovarian Cancer Tissue Xenografts
Ursula Kortmann et al.
CLINICAL CANCER RESEARCH (2011)
The Ability to Form Primary Tumor Xenografts Is Predictive of Increased Risk of Disease Recurrence in Early-Stage Non-Small Cell Lung Cancer
Thomas John et al.
CLINICAL CANCER RESEARCH (2011)
Expression of a Functional CCR2 Receptor Enhances Tumor Localization and Tumor Eradication by Retargeted Human T cells Expressing a Mesothelin-Specific Chimeric Antibody Receptor
Edmund K. Moon et al.
CLINICAL CANCER RESEARCH (2011)
Tumor Engraftment in Nude Mice and Enrichment in Stroma-Related Gene Pathways Predict Poor Survival and Resistance to Gemcitabine in Patients with Pancreatic Cancer
Ignacio Garrido-Laguna et al.
CLINICAL CANCER RESEARCH (2011)
Intrahepatically transplanted human cord blood cells reduce SW480 tumor growth in the presence of bispecific EpCAM/CD3 antibody
Annika Wulf-Goldenberg et al.
CYTOTHERAPY (2011)
Humanized tumor mice-A new model to study and manipulate the immune response in advanced cancer therapy
Anja K. Wege et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Gemcitabine Plus nab-Paclitaxel Is an Active Regimen in Patients With Advanced Pancreatic Cancer: A Phase I/II Trial
Daniel D. Von Hoff et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Human primary ductal carcinoma in situ (DCIS) subtype-specific pathology is preserved in a mouse intraductal (MIND) xenograft model
Kelli Elizabeth Valdez et al.
JOURNAL OF PATHOLOGY (2011)
A Pilot Clinical Study of Treatment Guided by Personalized Tumorgrafts in Patients with Advanced Cancer
Manuel Hidalgo et al.
MOLECULAR CANCER THERAPEUTICS (2011)
Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes
Yoko S. DeRose et al.
NATURE MEDICINE (2011)
Expression of HLA Class II Molecules in Humanized NOD.Rag1KO.IL2RgcKO Mice Is Critical for Development and Function of Human T and B Cells
Rebecca Danner et al.
PLOS ONE (2011)
IL-15 transpresentation promotes both human T-cell reconstitution and T-cell-dependent antibody responses in vivo
Nicholas D. Huntington et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Antitumor activity from antigen-specific CD8 T cells generated in vivo from genetically engineered human hematopoietic stem cells
Dimitrios N. Vatakis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Human thrombopoietin knockin mice efficiently support human hematopoiesis in vivo
Anthony Rongvaux et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Phenotypic heterogeneity and instability of human ovarian tumor-initiating cells
Jocelyn M. Stewart et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma
Olivier Keunen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
A Molecularly Annotated Platform of Patient-Derived Xenografts (Xenopatients) Identifies HER2 as an Effective Therapeutic Target in Cetuximab-Resistant Colorectal Cancer
Andrea Bertotti et al.
CANCER DISCOVERY (2011)
Mouse models of advanced spontaneous metastasis for experimental therapeutics
Giulio Francia et al.
NATURE REVIEWS CANCER (2011)
Integrated preclinical and clinical development of mTOR inhibitors in pancreatic cancer
I. Garrido-Laguna et al.
BRITISH JOURNAL OF CANCER (2010)
Multiple Injections of Electroporated Autologous T Cells Expressing a Chimeric Antigen Receptor Mediate Regression of Human Disseminated Tumor
Yangbing Zhao et al.
CANCER RESEARCH (2010)
Comparative Profiling of the Novel Epothilone, Sagopilone, in Xenografts Derived from Primary Non-Small Cell Lung Cancer
Stefanie Hammer et al.
CLINICAL CANCER RESEARCH (2010)
Establishment and Characterization of a Panel of Human Uveal Melanoma Xenografts Derived from Primary and/or Metastatic Tumors
Fariba Nemati et al.
CLINICAL CANCER RESEARCH (2010)
Patient-Derived First Generation Xenografts of Non-Small Cell Lung Cancers: Promising Tools for Predicting Drug Responses for Personalized Chemotherapy
Xin Dong et al.
CLINICAL CANCER RESEARCH (2010)
Parameters for establishing humanized mouse models to study human immunity: Analysis of human hematopoietic stem cell engraftment in three immunodeficient strains of mice bearing the IL2rγnull mutation
Michael A. Brehm et al.
CLINICAL IMMUNOLOGY (2010)
Local Regulation of Human Breast Xenograft Models
Jodie M. Fleming et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2010)
Identification of Predictive Markers of Response to the MEK1/2 Inhibitor Selumetinib (AZD6244) in K-ras-Mutated Colorectal Cancer
John J. Tentler et al.
MOLECULAR CANCER THERAPEUTICS (2010)
AML xenograft efficiency is significantly improved in NOD/SCID-IL2RG mice constitutively expressing human SCF, GM-CSF and IL-3
M. Wunderlich et al.
LEUKEMIA (2010)
Genome remodelling in a basal-like breast cancer metastasis and xenograft
Li Ding et al.
NATURE (2010)
Establishment of a rhabdomyosarcoma xenograft model in human-adapted mice
Seitz
ONCOLOGY REPORTS (2010)
Generation of functional human T-cell subsets with HLA-restricted immune responses in HLA class I expressing NOD/SCID/IL2rγnull humanized mice
Leonard D. Shultz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Recapitulation of endochondral bone formation using human adult mesenchymal stem cells as a paradigm for developmental engineering
Celeste Scotti et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Role of thymic cortex-specific self-peptides in positive selection of T cells
Yousuke Takahama et al.
SEMINARS IN IMMUNOLOGY (2010)
A Primary Xenograft Model of Small-Cell Lung Cancer Reveals Irreversible Changes in Gene Expression Imposed by Culture In vitro
Vincent C. Daniel et al.
CANCER RESEARCH (2009)
CD47 Is an Adverse Prognostic Factor and Therapeutic Antibody Target on Human Acute Myeloid Leukemia Stem Cells
Ravindra Majeti et al.
CELL (2009)
Human peripheral blood leucocyte non-obese diabetic-severe combined immunodeficiency interleukin-2 receptor gamma chain gene mouse model of xenogeneic graft-versus-host-like disease and the role of host major histocompatibility complex
M. A. King et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2009)
Immunodeficient Mouse Strains Display Marked Variability in Growth of Human Melanoma Lung Metastases
Beatriz M. Carreno et al.
CLINICAL CANCER RESEARCH (2009)
Defucosylated Anti-CCR4 Monoclonal Antibody Exerts Potent ADCC against Primary ATLL Cells Mediated by Autologous Human Immune Cells in NOD/Shi-scid, IL-2R gamma(null) Mice In Vivo
Asahi Ito et al.
JOURNAL OF IMMUNOLOGY (2009)
A robust xenotransplantation model for acute myeloid leukemia
P. V. Sanchez et al.
LEUKEMIA (2009)
Sagopilone crosses the blood-brain barrier in vivo to inhibit brain tumor growth and metastases
Jens Hoffmann et al.
NEURO-ONCOLOGY (2009)
Expression of human cytokines dramatically improves reconstitution of specific human-blood lineage cells in humanized mice
Qingfeng Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Coordinated epidermal growth factor receptor pathway gene overexpression predicts epidermal growth factor receptor inhibitor sensitivity in pancreatic cancer
Antonio Jimeno et al.
CANCER RESEARCH (2008)
Non-obese diabetic-recombination activating gene-1 (NOD-Rag1null) interleukin (IL)-2 receptor common gamma chain (IL2rγnull) null mice:: a radioresistant model for human lymphohaematopoietic engraftment
T. Pearson et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2008)
Establishment of Patient-Derived Non-Small Cell Lung Cancer Xenografts as Models for the Identification of Predictive Biomarkers
Iduna Fichtner et al.
CLINICAL CANCER RESEARCH (2008)
Xenografts of primary human gynecological tumors grown under the renal capsule of NOD/SCID mice show genetic stability during serial transplantation and respond to cytotoxic chemotherapy
Joshua Z. Press et al.
GYNECOLOGIC ONCOLOGY (2008)
Human acute leukemia cells injected in NOD/LtSz-scid/IL-2Rγ null mice generate a faster and more efficient disease compared to other NOD/scid-related strains
Alice Agliano et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rγnull mice
Michelle R. Simpson-Abelson et al.
JOURNAL OF IMMUNOLOGY (2008)
A new humanized mouse model of Epstein-Barr virus infection that reproduces persistent infection, lymphoproliferative disorder, and cell-mediated and humoral immune responses
Misako Yajima et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Efficient tumour formation by single human melanoma cells
Elsa Quintana et al.
NATURE (2008)
Polymorphism in Sirpa modulates engraftment of human hematopoietic stem cells
Katsuto Takenaka et al.
NATURE IMMUNOLOGY (2007)
A new model of patient tumor-derived breast cancer Xenografts for preclinical assays
Elisabetta Marangoni et al.
CLINICAL CANCER RESEARCH (2007)
A human colon cancer cell capable of initiating tumour growth in immunodeficient mice
Catherine A. O'Brien et al.
NATURE (2007)
Humanized mice mount specific adaptive and innate immune responses to EBV and TSST-1
Michael W. Melkus et al.
NATURE MEDICINE (2006)
An in vivo platform for translational drug development in pancreatic cancer
Belen Rubio-Viqueira et al.
CLINICAL CANCER RESEARCH (2006)
Xenografts of human hepatocellular carcinoma: A useful model for testing drugs
Hung Huynh et al.
CLINICAL CANCER RESEARCH (2006)
Reconstitution of a functional human immune system in immunodeficient mice through combined human fetal thymus/liver and CD34+ cell transplantation
Ping Lan et al.
BLOOD (2006)
Establishment in severe combined immunodeficiency mice of subrenal capsule xenografts and transplantable tumor lines from a variety of primary human lung cancers: Potential models for studying tumor progression-related changes
Jean-Claude Cutz et al.
CLINICAL CANCER RESEARCH (2006)
Primary tumour genetic alterations and intra-tumoral heterogeneity are maintained in xenografts of human colon cancers showing chromosome instability
D Guenot et al.
JOURNAL OF PATHOLOGY (2006)
Elimination of human leukemia cells in NOD/SCID mice by WT1-TCR gene-transduced human T cells
SA Xue et al.
BLOOD (2005)
Development of functional human blood and immune systems in NOD/SCID/IL2 receptor γ chainnull mice
F Ishikawa et al.
BLOOD (2005)
Development and characterization of efficient xenograft models for benign and malignant human prostate-tissue
YZ Wang et al.
PROSTATE (2005)
Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2Rγnull mice engrafted with mobilized human hemopoietic stem cells
LD Shultz et al.
JOURNAL OF IMMUNOLOGY (2005)
Establishment of subrenal capsule xenografts of primary human ovarian tumors in SCID mice: potential models
CH Lee et al.
GYNECOLOGIC ONCOLOGY (2005)
Reconstruction of functionally normal and malignant human breast tissues in mice
C Kuperwasser et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Development of a human adaptive immune system in cord blood cell-transplanted mice
E Traggiai et al.
SCIENCE (2004)
Integrating pharmacology and in vivo cancer models in preclinical and clinical drug development
JK Peterson et al.
EUROPEAN JOURNAL OF CANCER (2004)
Of mice and not men: Differences between mouse and human immunology
J Mestas et al.
JOURNAL OF IMMUNOLOGY (2004)
NOD/SCID mice engineered to express human IL-3, GM-CSF and Steel factor constitutively mobilize engrafted human progenitors and compromise human stem cell regeneration
FE Nicolini et al.
LEUKEMIA (2004)
A mouse model of human adaptive immune functions:: HLA-A2.1-/HLA-DR1-transgenic H-2 class I-/class II-knockout mice
A Pajot et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2004)
Orthotopic transplantation models of pancreatic adenocarcinoma derived from cell lines and primary tumors and displaying varying metastatic activity
P Loukopoulos et al.
PANCREAS (2004)
Species differences in the structure and function of the immune system
PJ Haley
TOXICOLOGY (2003)
Serial in vivo imaging of the targeted migration of human HSV-TK-transduced antigen-specific lymphocytes
G Koehne et al.
NATURE BIOTECHNOLOGY (2003)
Prospective identification of tumorigenic breast cancer cells
M Al-Hajj et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
NOD/SCID/γcnull mouse:: an excellent recipient mouse model for engraftment of human cells
M Ito et al.
BLOOD (2002)
Intrathymic and extrathymic development of human plasmacytoid dendritic cell precursors in vivo
K Weijer et al.
BLOOD (2002)
Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials
JI Johnson et al.
BRITISH JOURNAL OF CANCER (2001)
Therapy of human tumors in NOD/SCID mice with patient-derived reactivated memory T cells from bone marrow
M Feuerer et al.
NATURE MEDICINE (2001)
Development of a panel of 15 human ovarian cancer xenografts for drug screening and determination of the role of the glutathione detoxification system
GM Kolfschoten et al.
GYNECOLOGIC ONCOLOGY (2000)
NOD/LtSz-Rag1(null) mice: An immunodeficient and radioresistant model for engraftment of human hematolymphoid cells, HIV infection, and adoptive transfer of NOD mouse diabetogenic T cells
LD Shultz et al.
JOURNAL OF IMMUNOLOGY (2000)
分享论文
